Rautio A, Eliasson M, Stegmayr B: Favorable trends in the incidence and outcome in stroke in nondiabetic and diabetic subjects: findings from the Northern Sweden MONICA Stroke Registry in 1985 to 2003. Stroke. 2008, 39: 3137-3144. 10.1161/STROKEAHA.107.504100.
Article
PubMed
Google Scholar
Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR: Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke. 2007, 38: 1739-1743. 10.1161/STROKEAHA.106.481390.
Article
PubMed
Google Scholar
Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA: Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011, 42: 517-584. 10.1161/STR.0b013e3181fcb238.
Article
PubMed
Google Scholar
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009, 119: 351-357. 10.1161/CIRCULATIONAHA.108.191305.
Article
PubMed
Google Scholar
Standards of medical care in diabetes-2010. Diabetes Care. 2010, 33: S11-S61. 10.2337/dc10-S011.
Ceriello A, Ihnat MA: `Glycemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010, 27: 862-867. 10.1111/j.1464-5491.2010.02967.x.
CAS
Article
PubMed
Google Scholar
Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH: Glucose variability; does it matter?. Endocr Rev. 2010, 31: 171-182. 10.1210/er.2009-0021.
CAS
Article
PubMed
Google Scholar
Ceriello A, Kilpatrick ES: Glycemic variability: both sides of the story. Diabetes Care. 2013, 36: S272-S275. 10.2337/dcS13-2030.
Article
PubMed
PubMed Central
Google Scholar
Kohnert KD, Freyse EJ, Salzsieder E: Glycaemic variability and pancreatic β-cell dysfunction. Curr Diabetes Rev. 2012, 8: 345-354. 10.2174/157339912802083513.
CAS
Article
PubMed
Google Scholar
Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D: Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008, 57: 1349-1354. 10.2337/db08-0063.
CAS
Article
PubMed
Google Scholar
Muggeo M, Verlato G, Bonora E, Bressan F, Girotto S, Corbellini M, Gemma ML, Moghetti P, Zenere M, Cacciatori V, Zoppini G, De Marco R: The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia. 1995, 38: 318-325. 10.1007/BF00400637.
CAS
Article
PubMed
Google Scholar
Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, Verlato G: Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the verona diabetes Study. Diabetes Care. 2000, 23: 45-50. 10.2337/diacare.23.1.45.
CAS
Article
PubMed
Google Scholar
Lin CC, Li CI, Yang SY, Liu CS, Chen CC, Fuh MM, Chen W, Li TC: Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. Am J Med. 2012, 125: e9-e18. 10.1016/j.amjmed.2011.07.027.
PubMed
Google Scholar
Lin CC, Li CI, Liu CS, Lin WY, Chen CC, Yang SY, Lee CC, Li TC: Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study. Endocr Relat Cancer. 2012, 19: 473-483. 10.1530/ERC-12-0038.
CAS
Article
PubMed
Google Scholar
Nalysnyk L, Hernandez-Medina M, Krishnarajah G: Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010, 12: 288-298. 10.1111/j.1463-1326.2009.01160.x.
CAS
Article
PubMed
Google Scholar
Wu VC, Huang TM, Wu PC, Wang WJ, Chao CT, Yang SY, Shiao CC, Hu FC, Lai CF, Lin YF, Han YY, Chen YS, Hsu RB, Young GH, Wang SS, Tsai PR, Chen YM, Chao TT, Ko WJ, Wu KD: Preoperative proteinuria is associated with long-term progression to chronic dialysis and mortality after coronary artery bypass grafting surgery. PLoS One. 2012, 7: e27687-10.1371/journal.pone.0027687.
CAS
Article
PubMed
PubMed Central
Google Scholar
National Health Insurance Administration, Ministry of Health and Welfare: The National Health Insurance Statistics, 2010; 2010. Available at: ; In Chinese., [http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_id=4010]
Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML: Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011, 20: 236-242. 10.1002/pds.2087.
Article
PubMed
Google Scholar
Kilpatrick ES, Rigby AS, Atkin S: A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care. 2008, 31: 2022-2198. 10.2337/dc08-0864.
Article
Google Scholar
Lunn M, McNeil D: Applying Cox regression to competing risks. Biometrics. 1995, 51: 524-532. 10.2307/2532940.
CAS
Article
PubMed
Google Scholar
Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM: Tests of glycemia in diabetes. Diabetes Care. 2003, 26: S106-S108. 10.2337/diacare.26.3.777.
Article
PubMed
Google Scholar
Heo SH, Lee SH, Kim BJ, Kang BS, Yoon BW: Does glycated hemoglobin have clinical significance in ischemic stroke patients?. Clin Neurol Neurosurg. 2010, 112: 98-102. 10.1016/j.clineuro.2009.08.024.
Article
PubMed
Google Scholar
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321: 405-412. 10.1136/bmj.321.7258.405.
CAS
Article
PubMed
PubMed Central
Google Scholar
Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR: Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol. 2005, 4: 821-826. 10.1016/S1474-4422(05)70227-1.
CAS
Article
PubMed
Google Scholar
Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-2559. 10.1056/NEJMoa0802743.
CAS
Article
PubMed
Google Scholar
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009, 360: 129-139. 10.1056/NEJMoa0808431.
CAS
Article
PubMed
Google Scholar
Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572. 10.1056/NEJMicm066227.
CAS
Article
PubMed
Google Scholar
Brownlee M, Hirsch IB: Glycemic variability: a hemoglobin A1c independent risk factor for diabetic complications. JAMA. 2006, 295: 1707-1708. 10.1001/jama.295.14.1707.
CAS
Article
PubMed
Google Scholar
Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM: Fasting plasma glucose variability as a risk factor of retinopathy in type 2 diabetic patients. J Diabetes Complications. 2003, 17: 78-81. 10.1016/S1056-8727(02)00197-6.
Article
PubMed
Google Scholar
Zoppini G, Verlato G, Targher G, Bonora E, Trombetta M, Muggeo M: The Verona Diabetes Study. Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. Diabetes Metab Res Rev. 2008, 24: 624-628. 10.1002/dmrr.897.
Article
PubMed
Google Scholar
Hirsch IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control?. J Diabetes Complications. 2005, 19: 178-181. 10.1016/j.jdiacomp.2004.10.001.
Article
PubMed
Google Scholar
Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A: Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med. 2011, 37: 583-593. 10.1007/s00134-010-2129-5.
Article
PubMed
PubMed Central
Google Scholar
Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006, 295: 1681-1687. 10.1001/jama.295.14.1681.
CAS
Article
PubMed
Google Scholar
Hu Y, Liu W, Huang R, Zhang X: Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. Atherosclerosis. 2010, 210: 302-306. 10.1016/j.atherosclerosis.2009.11.015.
CAS
Article
PubMed
Google Scholar
Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M: Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000, 23: 1830-1834. 10.2337/diacare.23.12.1830.
CAS
Article
PubMed
Google Scholar
Barbieri M, Rizzo MR, Marfella R, Boccardi V, Esposito A, Pansini A, Paolisso G: Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors. Atherosclerosis. 2013, 227: 349-354. 10.1016/j.atherosclerosis.2012.12.018.
CAS
Article
PubMed
Google Scholar
Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S: Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010, 363: 1410-1418. 10.1056/NEJMoa1003795.
CAS
Article
PubMed
Google Scholar
Yakubovich N, Gerstein HC: Serious cardiovascular outcomes in diabetes: the role of hypoglycemia. Circulation. 2011, 123: 342-348. 10.1161/CIRCULATIONAHA.110.948489.
Article
PubMed
Google Scholar
Ceriello A, Novials A, Ortega E, La Sala L, Pujadas G, Testa R, Bonfigli AR, Esposito K, Giugliano D: Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012, 61: 2993-2997. 10.2337/db12-0224.
CAS
Article
PubMed
PubMed Central
Google Scholar
Service FJ: Glucose variability. Diabetes. 2013, 62: 1398-1404. 10.2337/db12-1396.
CAS
Article
PubMed
PubMed Central
Google Scholar
DeVries JH: Glucose variability: where it is important and how to measure it. Diabetes. 2013, 62: 1405-1408. 10.2337/db12-1610.
CAS
Article
PubMed
PubMed Central
Google Scholar
Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001, 161: 397-405. 10.1001/archinte.161.3.397.
Meigs JB, Nathan DM, D'Agostino RB, Wilson PW: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002, 25: 1845-1850. 10.2337/diacare.25.10.1845.
Article
PubMed
Google Scholar